Patents by Inventor Shuji KINOSHITA

Shuji KINOSHITA has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20240188227
    Abstract: A wiring board includes: a substrate having transparency; a mesh wiring portion arranged on the substrate and including a plurality of wiring lines; and a dummy wiring portion arranged around the mesh wiring portion and including a plurality of dummy wiring lines electrically independent of the wiring lines. The mesh wiring portion is comprised of an iterative array of a predetermined unit pattern in a first direction. In the first direction, a gap between the mesh wiring portion and the dummy wiring portion is 0.01 times or more and 0.2 times or less a pitch of the unit pattern in the first direction.
    Type: Application
    Filed: April 4, 2022
    Publication date: June 6, 2024
    Applicant: DAI NIPPON PRINTING CO., LTD.
    Inventors: Keita IIMURA, Shuji KAWAGUCHI, Kazuki KINOSHITA, Hidetoshi IIOKA, Seiji TAKE
  • Publication number: 20240121999
    Abstract: A multilayer body for an image display device includes a wiring substrate including a substrate having transparency, and a mesh wiring layer disposed on the substrate; and a dielectric layer stacked on the wiring substrate. The dielectric layer and the substrate have a total thickness of 50 ?m or more and 500 ?m or less.
    Type: Application
    Filed: April 4, 2022
    Publication date: April 11, 2024
    Applicant: DAI NIPPON PRINTING CO., LTD.
    Inventors: Keita IIMURA, Shuji KAWAGUCHI, Kazuki KINOSHITA, Hidetoshi IIOKA, Seiji TAKE
  • Publication number: 20230263786
    Abstract: Provided herein are methods for reducing, minimizing, or controlling drug-drug interactions resulting from administration of a first drug that is vadadustat (i.e., {[5-(3- chlorophenyl)-3-hydroxypyridine-2-carbonyl]amino}acetic acid (Compound 1)) and a second drug (for example, a drug comprising a multivalent cation such as calcium, iron, magnesium, lanthanum, aluminum, and the like; a statin drug; sulfasalazine; or furosemide), to a subject.
    Type: Application
    Filed: June 17, 2021
    Publication date: August 24, 2023
    Applicants: Akebia Therapeutics, Inc., Mitsubishi Tanabe Pharma Corporation
    Inventors: Ajit CHAVAN, Rishikesh SAWANT, Yoshimasa KOKADO, Takehiro NANJO, Shuji KINOSHITA, Naomi KONISHI